ClinicalTrials.Veeva

Menu

Growth and Tolerance of Healthy Term Infants to a New Infant Formula

Abbott logo

Abbott

Status and phase

Terminated
Phase 3

Conditions

Healthy Term Infants

Treatments

Other: Investigational Infant Formula #1
Other: Human Milk
Other: Investigational Infant Formula #2
Other: Milk based infant formula powder

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.

Enrollment

399 patients

Sex

All

Ages

1 to 11 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • in good health
  • singleton full term birth
  • Birth weight > 2490 g.
  • Infant is between 0 and 11 days of age
  • Infants using medications , home remedies , herbal preparations, prebiotics, probiotics or rehydration fluids that might affect GI tolerance
  • If formula-fed, parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study
  • If human milk-fed, parent(s) confirm their intention to feed their infant human milk as the sole source of nutrition
  • not consuming vitamin or mineral supplements, solid foods or juices through the duration of the study

Exclusion criteria

adverse maternal, fetal or infant medical history with potential for effects on tolerance, growth, and/or development.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

399 participants in 4 patient groups

Infant Formula #1
Active Comparator group
Description:
Milk-based Infant Formula Powder
Treatment:
Other: Milk based infant formula powder
Investigational Infant Formula #1
Experimental group
Description:
Investigational Milk-based Infant Formula Powder
Treatment:
Other: Investigational Infant Formula #1
Investigational Infant Formula #2
Experimental group
Description:
Investigational Milk based infant formula powder
Treatment:
Other: Investigational Infant Formula #2
Human Milk
Active Comparator group
Description:
Reference group
Treatment:
Other: Human Milk

Trial contacts and locations

20

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems